Live feed
·
INSIDERFiling
Nurix Therapeutics Inc. logo

Chief Financial Officer Van Houte Hans converted options into 11,496 shares and sold $60,767 worth of shares (3,661 units at $16.60), increasing direct ownership by 21% to 45,427 units (SEC Form 4)